Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

8.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.7K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
X-linked Traits01:19

X-linked Traits

58.3K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
58.3K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

356
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
356
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

86.1K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.1K
Sex-linked Disorders01:43

Sex-linked Disorders

108.4K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
108.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reshaping the Battlefield: Reprogramming the Melanoma Tumour Microenvironment (TME) by Anti-CTLA-4, Anti-PD-1, and Anti-PD-L1 Monotherapy and Combination Therapy: A Systematic Review and Meta-Analysis of Preclinical and Clinical Evidence.

Cells·2026
Same author

Feasibility of Causality-Aware Machine Learning for Drug Safety on OMOP-CDM.

Studies in health technology and informatics·2026
Same author

Integrating Multi-Source Biomedical Data for Adverse Drug Reaction Analysis: A Knowledge Graph Approach.

Studies in health technology and informatics·2026
Same author

Fabrication and biocompatibility evaluation of 3D printed tablets using Digital Light Processing (DLP) printing for the controlled release of ketoprofen.

International journal of pharmaceutics·2026
Same author

Omics-Derived Prognostic Biomarkers in Tongue Squamous Cell Carcinoma: A Systematic Review with Risk-of-Bias Appraisal and Translational Prioritization.

Current issues in molecular biology·2026
Same author

Designing a children's health exposomics study protocol: The CHILDREN_FIRST multi-country prospective cohort using multi-omics and personalized prevention approaches.

PloS one·2026

Related Experiment Video

Updated: Jan 20, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.4K

Linking Exome Sequencing Data with Drug Response Aberrations.

Konstantinos Kyriakidis1, Alexandra Charalampidou2, Pantelis Natsiavas3,4

  • 1Lab. of Biological Chemistry, School of Medicine, Aristotle University of Thessaloniki, Greece.

Studies in Health Technology and Informatics
|August 24, 2019
PubMed
Summary

This study introduces a novel method to interpret genomic data, translating patient profiles into drug response predictions. This approach integrates pharmacogenomic data into sequencing analysis for actionable clinical insights.

Keywords:
High-Throughput Nucleotide SequencingPharmacogenomic VariantsPolymorphism

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K
Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
04:58

Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance

Published on: December 13, 2024

4.0K

Related Experiment Videos

Last Updated: Jan 20, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.4K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K
Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
04:58

Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance

Published on: December 13, 2024

4.0K

Area of Science:

  • Genomics
  • Pharmacogenomics
  • Computational Biology

Background:

  • Next-generation sequencing (NGS) has enabled advanced -omics applications.
  • Computational pipelines analyze complex genomic data but struggle with actionable interpretation.
  • Translating genomic data into clinically relevant drug response information remains a challenge.

Purpose of the Study:

  • To develop a method for translating patient genomic profiles into drug response aberrations.
  • To integrate pharmacogenomic data within existing sequencing data analysis pipelines.
  • To bridge the gap between raw genomic data and actionable clinical evidence.

Main Methods:

  • Integration of pharmacogenomic datasets with patient sequencing data.
  • Development of a computational pipeline to analyze combined data.
  • Method for translating genomic profiles into predicted drug response variations.

Main Results:

  • Demonstrated a method to predict drug response aberrations from patient genomic profiles.
  • Successfully integrated pharmacogenomic data into sequencing analysis workflows.
  • Provided a framework for generating actionable evidence from -omics data.

Conclusions:

  • The proposed method effectively translates genomic data into drug response insights.
  • Integration of pharmacogenomics enhances the clinical utility of sequencing data analysis.
  • This approach offers a pathway to personalized medicine by informing drug selection.